e-learning
resources
Berlin 2008
Monday, 06.10.2008
Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Implementation of evidence based strategies for prevention of ventilator-associated pneumonia
R. Seligman, S. Ribeiro, R. Kuchenbecker, L. Konckewicz, D. Vieira, R. Santos, B. Afonso, D. Machado (Porto Alegre, Brazil)
Source:
Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Session:
Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Session type:
Thematic Poster Session
Number:
2304
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Seligman, S. Ribeiro, R. Kuchenbecker, L. Konckewicz, D. Vieira, R. Santos, B. Afonso, D. Machado (Porto Alegre, Brazil). Implementation of evidence based strategies for prevention of ventilator-associated pneumonia. Eur Respir J 2008; 32: Suppl. 52, 2304
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
VAP prevention: pharmacological strategies
Source: Eur Respir Mon 2011; 53: 74-82
Year: 2011
Update on therapeutic strategies in community-acquired pneumonia
Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice
Year: 2017
Evidence on measures for the prevention of ventilator-associated pneumonia
Source: Eur Respir J 2007; 30: 1193-1207
Year: 2007
Impact of guidelines on HAP and VAP outcomes
Source: Eur Respir Mon 2011; 53: 66-73
Year: 2011
Management of community-acquired pneumonia: new evidence-based algorithms.
Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections
Year: 2021
Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia
Source: Eur Respir J 2011; 37: 1332-1339
Year: 2011
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Eur Respir J, 50 (3) 1700582; 10.1183/13993003.00582-2017
Year: 2017
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Guideline 2017
Year: 2017
Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia
Source: ERS Course 2018 - Respiratory Infections
Year: 2018
Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect
Source: Eur Respir J 2011; 39: 7-8
Year: 2012
Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect
Source: Eur Respir J 2012; 39: 7-8
Year: 2012
The impact of 2016 guideline on clinical practice for the management of hospital-acquired and ventilator-associated pneumonia in Taiwan
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018
Validation of treatment adequacy of current guidelines for hospital-acquired pneumonia
Source: Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU
Year: 2003
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
Source: Guideline 2018
Year: 2019
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
Source: ERJ Open Res, 4 (2) 00028-2018; 10.1183/23120541.00028-2018
Year: 2018
Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines
Source: Eur Respir J 2003 Dec 01;22(6):876-882
Year: 2003
Update on preventing and managing hospital-acquired and ventilatory-associated pneumonia
Source: International Congress 2019 – State of the art session: Respiratory infections
Year: 2019
Prevention is better than cure: time to change the focus of community-acquired pneumonia management
Source: Eur Respir J 2015; 45: 1524-1525
Year: 2015
Efficacy of a ventilator bundle for the prevention of the ventilator-associated pneumonia
Source: Annual Congress 2011 - Mechanical ventilation and lung injury: new advances
Year: 2011
Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome
Source: Eur Respir J 2008; 32: 892-901
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept